AstraZeneca drafts plan to spin off China business amid tensions

AstraZeneca drafts plan to spin off China business amid tensions

Anglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner